Goldmann R, Folwarczny S, Skrízalová A, Pieniazková V
Interní oddĕlení nemocnice, Ceský Tĕsín.
Vnitr Lek. 1997 Apr;43(4):217-20.
In a group of 273 patients with a recently developed atrial fibrillation the authors compared the success of cardioversion in a group of 141 patients using quinidine and a group of 132 patients where for cardioversion different preparations were used. The results of the investigation confirmed the advantages of quinidine as an antiarrhythmic drug used for pharmacological cardioversion of atrial fibrillation.
在一组273例近期发生心房颤动的患者中，作者比较了141例使用奎尼丁的患者和132例使用不同制剂进行心脏复律的患者的复律成功率。研究结果证实了奎尼丁作为用于心房颤动药物复律的抗心律失常药物的优势。
